Roopal MD - AbbVie Executive Officer
| ABBV Stock | 25.39 0.22 0.86% |
Executive
Roopal MD is Executive Officer of AbbVie Inc CDR
| Age | 52 |
| Address | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
| Phone | 847 932 7900 |
| Web | https://www.abbvie.com |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Brian CA | Partners Value Investments | 65 | |
| Allison Smith | Partners Value Investments | N/A | |
| Barry Brotherson | Everyday People Financial | N/A | |
| CLU CFP | iA Financial | N/A | |
| James Esq | Partners Value Investments | 56 | |
| Murray Oxby | CI Financial Corp | N/A | |
| Manisha Burman | CI Financial Corp | N/A | |
| Jason Weckwerth | Partners Value Investments | N/A | |
| Gary Coles | iA Financial | N/A | |
| Alasdair Skeoch | Everyday People Financial | N/A | |
| Julie Silcox | CI Financial Corp | N/A | |
| Pierre Picard | iA Financial | N/A | |
| Alnoor Jiwani | iA Financial | N/A | |
| Jason CFA | CI Financial Corp | N/A | |
| Bradley Howard | CI Financial Corp | N/A | |
| LLB BA | CI Financial Corp | N/A | |
| Darren Wagner | Everyday People Financial | 52 | |
| Renata Berlingo | Everyday People Financial | 42 | |
| Alain MSc | iA Financial | N/A | |
| Richard Carty | Economic Investment Trust | 56 | |
| Morgan Russel | Everyday People Financial | 50 | |
Management Performance
| Return On Equity | 0.56 | ||||
| Return On Asset | 0.0772 |
AbbVie Inc CDR Leadership Team
Elected by the shareholders, the AbbVie's board of directors comprises two types of representatives: AbbVie inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AbbVie. The board's role is to monitor AbbVie's management team and ensure that shareholders' interests are well served. AbbVie's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AbbVie's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Gonzalez, Executive Chairman | ||
| Tracie Haas, Brand Responsibility | ||
| Sanjay Narayan, Chief SVP | ||
| Roopal MD, Executive Officer | ||
| Assil Omar, VP Officer | ||
| Greg Miley, Senior Affairs | ||
| Robert Michael, President COO | ||
| Elizabeth Shea, Senior Relations | ||
| Jeffrey Stewart, Executive Officer | ||
| WulffErik Borcke, Senior Oncology | ||
| Perry Siatis, General VP | ||
| Timothy Richmond, Executive Officer | ||
| Scott Reents, Executive CFO | ||
| Azita SalekiGerhardt, Executive COO | ||
| Thomas MD, Senior Research |
AbbVie Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AbbVie a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.56 | ||||
| Return On Asset | 0.0772 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.29 % | ||||
| Current Valuation | 526.06 B | ||||
| Shares Outstanding | 16.7 B | ||||
| Price To Book | 50.34 X | ||||
| Price To Sales | 7.92 X | ||||
| Revenue | 55.53 B | ||||
| Gross Profit | 41.53 B |
Pair Trading with AbbVie
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbbVie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will appreciate offsetting losses from the drop in the long position's value.Moving together with AbbVie Stock
| 0.69 | CMC | Cielo Waste Solutions Earnings Call This Week | PairCorr |
Moving against AbbVie Stock
The ability to find closely correlated positions to AbbVie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbbVie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbbVie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbbVie Inc CDR to buy it.
The correlation of AbbVie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbbVie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbbVie Inc CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbbVie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in AbbVie Stock
AbbVie financial ratios help investors to determine whether AbbVie Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AbbVie with respect to the benefits of owning AbbVie security.